Amkay Products Ltd vs Invicta Diagnostic Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Apr 02, 2026

Key Highlights

The Latest Trading Price of Amkay Products Ltd is ₹ 52 as of 30 Mar 15:30 . The P/E Ratio of Amkay Products Ltd is 0 as of March 2024 .The P/E Ratio of Invicta Diagnostic Ltd is 0 as of March 2024 . The Market Cap of Amkay Products Ltd is ₹ 0 crore as of March 2024 .The Market Cap of Invicta Diagnostic Ltd is ₹ 0 crore as of March 2024 . The Dividend Payout of Amkay Products Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Invicta Diagnostic Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Amkay Products Ltd

Amkay Products Ltd was originally incorporated as 'Amkay Products Private Limited' on October 25, 2007 with the Registrar of Companies, Mumbai.
Subsequently, the Company was converted into a Public Limited Company and the name was changed from 'Amkay Products Private Limited' to 'Amkay Products Limited' vide a fresh Certificate of Incorporation dated August 28, 2023, issued by the Registrar of Companies, Maharashtra, Mumbai. The Company manufacture, assemble & market a comprehensive portfolio of medical devices, disposables and other Healthcare Products like Face Mask, Alcohol Swabs, Steel/ Plastic Lancet Needles, Air Bed, Apron, Digital Thermometer, Nebulizer, Shoe Cover, BP Monitor, Pulse Oximeter, Surgeon Cap etc. used by healthcare centers, hospitals/clinics, nursing homes etc. widely spread across India.

About Invicta Diagnostic Ltd

Invicta Diagnostic Limited was incorporated as Limited Liability Partnership under the name 'Invicta Diagnostic LLP' vide Certificate of Incorporation dated January 22, 2021 issued by Assistant Registrar of Companies, Central Registration Centre.
Further, Invicta Diagnostic LLP converted into a Private Limited Company as 'Invicta Diagnostic Private Limited' dated December 01, 2023.
Subsequently, Company converted from a Private Limited to a Public Limited Company, and the name was changed to 'Invicta Diagnostic Limited' and a fresh Certificate of Incorporation dated July 02, 2024 was issued by the Central Processing Centre. Invicta Diagnostic Limited is an innovative diagnostic chain in Mumbai Metropolitan Region (MMR) offering comprehensive radiology and pathology solutions.
It offer a one-stop solution for pathology and radiology testing services such as imaging (including radiology) and pathology/clinical laboratory to customers through a network, consisting of 8 diagnostic centres and 1 centralised laboratory across Mumbai Metropolitan Region in Maharashtra.

FAQs for the comparison of Amkay Products Ltd and Invicta Diagnostic Ltd

Which company has a larger market capitalization, Amkay Products Ltd or Invicta Diagnostic Ltd?

Market cap of Amkay Products Ltd is 45 Cr while Market cap of Invicta Diagnostic Ltd is 89 Cr

What are the key factors driving the stock performance of Amkay Products Ltd and Invicta Diagnostic Ltd?

The stock performance of Amkay Products Ltd and Invicta Diagnostic Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Amkay Products Ltd and Invicta Diagnostic Ltd?

As of April 2, 2026, the Amkay Products Ltd stock price is INR ₹52.0. On the other hand, Invicta Diagnostic Ltd stock price is INR ₹71.0.

How do dividend payouts of Amkay Products Ltd and Invicta Diagnostic Ltd compare?

To compare the dividend payouts of Amkay Products Ltd and Invicta Diagnostic Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.